NCT00304720 Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor Status UNKNOWN Phase PHASE2
NCT00303719 Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy Status TERMINATED Phase PHASE2
NCT00301275 Assessing Free Immunoglobulin Light Chains in Patients With Myeloma Status COMPLETED Phase N/A
NCT00300664 A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. Status COMPLETED Phase PHASE2/PHASE3
NCT00299780 Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. Status COMPLETED Phase PHASE1
NCT00293111 Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM) Status TERMINATED Phase PHASE2
NCT00291538 Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00287872 Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00281476 The Effect of High Dose Simvastatine on Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT00276536 Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma Status COMPLETED Phase PHASE1
NCT00276159 Study of Immune Response Modifier in the Treatment of Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation Status TERMINATED Phase PHASE2
NCT00273936 Trial of AVN-944 in Patients With Advanced Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT00270166 The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy Status COMPLETED Phase PHASE3
NCT00270101 The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00263484 Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma Status COMPLETED Phase PHASE2